These findings reveal a role for ADAM10 in molecular specificity of the host-pathogen interaction and suggest that ADAM10 may represent a promising target for sepsis therapies in a specific and definable subset of bacterial infections. This evidence concerns the gene ADAM10 and bacterial infectious disease.